Driven by the Rising Demand for 3D Printing Technology in Healthcare and Pharmaceutical Sectors, The Global 3D Bioprinting Market is forecasted to Cross US$ 5 Bn By 2028 says Ken Research Study.
3D bioprinting is a technology where bioinks, mixed with living cells, are printed in 3D to construct natural tissue-like three-dimensional structures. This technology can be used in various research areas, such as tissue engineering and new drug development.
“Ken Research shares 3 key insights on this high-opportunity market from its latest research study”
1. Increasing Use of 3D Bioprinting in Pharmaceutical and Cosmetology Industries Provide an Opportunity for the Market Growth
According to Ken Research Analysis, the Global 3D Bioprinting Market was valued at ~US$ 1 billion in 2017. It is estimated to be ~US$ 2 billion in 2022 and is forecasted to reach a market size of ~US$ 5 billion by 2028, growing at a CAGR of ~15% from 2022 to 2028.
Request for Free Sample Report @https://www.kenresearch.com/sample-report.php?Frmdetails=NTk2MTY4
Several pharmaceutical companies are increasingly adopting 3D bioprinting products and technologies in the drug discovery and development process. The 3D bioprinting method enables companies to test drugs safely and at lower costs as compared to the traditional drug testing method.
The use of 3D bioprinting increased in the cosmetics industry, with growing awareness of this technique among users. For instance, the European Commission banned animal testing for cosmetic products, as a result, a number of cosmetic and wellness industries have adopted 3D bioprinting to develop novel 3D tissue models as well as drug testing approaches.
2. The Rising Global Demand for Organs Transplants is Fuelling the Market Worldwide
3D printing is gaining popularity in the healthcare industry due to the potential to develop complex solid organs such as hearts, kidneys, and lungs for the purpose of transplantation. As opposed to the conventional replacement of failing or damaged organs, 3D-printed organs are unlikely to pose any hazards as there is the utilization of cells taken from the patient’s body.
3D bioprinting has great potential in the medical field, as it allows medical professionals to replace broken bones and develop new organs for transplantation. It also enables the printing of prosthetic limbs, which can be replaced in patients with missing limbs. Moreover, the 3D printing process enables faster development of organs and tissues as compared to the traditional process.
The graph below represents the total number of organ transplants performed vs the number of patients waiting for the transplants:
3. Difficulty in Process Control and the High Cost of 3D Bioprinters are the Major Challenges Faced by the Market
Consistency in the additive manufacturing process is altered between machines due to uncontrolled process variables and material differences. There is only limited data available regarding process control, so the capacity to develop detailed and accurate mathematical models through additive manufacturing has become difficult.
Request for Free Sample Report @https://www.kenresearch.com/sample-report.php?Frmdetails=NTk2MTY4
The 3D printers are very expensive compared to other printer models. One of the major factors is due to the initial investment to attain the 3D printer equipment. The factors such as material, model complexity, and labor affect the price of 3D printing. 3D printing can cost anywhere from $3 up to thousands of dollars.
The graph below represents some 3D bioprinters with their respective prices:
Key Topics Covered in the Report
- Snapshot of Global 3D Bioprinting Market
- Industry Value Chain and Ecosystem Analysis
- Market size and Segmentation of the Global 3D Bioprinting Market
- Historic Growth of Overall Global 3D Bioprinting Market and Segments
- Competition Scenario of the Market and Key Developments of Competitors
- Porter’s 5 Forces Analysis of Global 3D Bioprinting Industry
- Overview, Product Offerings, Strengths, & Weaknesses of Key Competitors
- Covid-19 Impact on the Overall Global 3D Bioprinting Market
- Future Market Forecast and Growth Rates of the Global 3D Bioprinting Market and Segments
- Analysis of Global 3D Bioprinting Market
- Major Production/Supply and Consumption/Demand Hubs within Each Region
- Major Country-wise Historic and Future Market Growth Rates of the Total Market and Segments
- Overview of Notable Emerging Competitor Companies within Each Region
Notable Key Players Mentioned in the Report
- Organovo Holdings, Inc.
- Inventia Life Science
- Poietis
- VIVAX BIO, LLC
- CYFUSE BIOMEDICAL K.K.
- 3D Bioprinting Solutions
- CELLINK
- BICO – THE BIO CONVERGENCE COMPANY
- CollPlant Biotechnologies Ltd.
- Aspect Biosystems Ltd.
Notable Emerging Companies Mentioned in the Report
- Organovo
- Prellis Biologics
- Pandorum Technologies
- Regenovo Biotechnology
Key Target Audience – Organizations and Entities Who Can Benefit by Subscribing This Report
- 3D Bioprinting Manufacturers
- 3D Bioprinting Suppliers
- 3D Bioprinters Manufacturers
- Bioinks Manufacturers
- Living Cells Suppliers
- Hydrogels Suppliers
- Extracellular Matrices Suppliers
- 3D Bioprinting Distributors
- Emerging and Startup Companies in 3D Bioprinting
- Different Types of 3D Bioprinting Manufacturing Hubs
- Government Departments of Healthcare
- Government Departments of Pharmaceuticals
- Ministries and Departments of Bio-based Materials
- Importers and Distributors of 3D Bioprinting
Period Captured in the Report
- Historical Period: 2017-2021
- Forecast Period: 2022E-2028F
For more insights on the market intelligence, refer to the link below: –
Global 3D Bioprinting Market: Ken Research
Follow Us –
LinkedIn | Instagram | Facebook | Twitter | YouTube
